Aadi Bioscience, Inc. (NASDAQ:AADI) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET

Company Participants

Marcy Graham - SVP of IR and Corporate Communications

Neil Desai - President and CEO

Brendan Delaney - COO

Loretta Itri - Chief Medical Officer

Scott Giacobello - CFO

Conference Call Participants

Boris Peaker - Cowen

Jiale Song - Jefferies

Robert Burns - H.C. Wainwright

Operator

Good day and thank you for standing by. Welcome to the Aadi Bioscience, Inc. Second Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to Marcy Graham, Senior Vice President of Investor Relations and Corporate Communications at Aadi Bioscience. Ms. Graham, please go ahead.

Marcy Graham

Thank you. Good morning and welcome to the Aadi Bioscience conference call to review results of and provide an update on second quarter 2022.

Joining me on the call today is our President and CEO, Neil Desai, who will provide an overview of the quarter followed by Chief Operating Officer, Brendan Delaney, who will give us an update on our early commercial progress. Next will be our Chief Medical Officer, Dr. Loretta Itri, who will give us a brief update on our clinical progress, followed by our CFO, Scott Giacobello with review of our financial performance during the period. We will close with some final thoughts from Neil and then open the line for questions.

Before we get started a quick reminder that statements made on the call today will include forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties or other factors, including those set forth in the Risk Factors section of our annual and quarterly filings with the Security and Exchange Commission, which can be found at www.sec.gov, or on our website at www.aadibio.com.

In addition, any forward-looking statements made on this call represent our views only as of today, August 10, 2022 and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update or revise any forward-looking statements.

With that, I will turn the call over to Neil for his opening statements, Neil?

Neil Desai

Thank you, Marcy. Good morning everyone and thank you for joining us today.